Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHumacyte, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.23 | -$0.23 | -$0.23 |
| Q2 2024 | 3 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2024 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q4 2024 | 3 | -$0.27 | -$0.23 | -$0.25 |
| Q1 2025 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q2 2025 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q3 2025 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q4 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q1 2026 | 1 | $0.29 | $0.29 | $0.29 |
| Q2 2026 | 1 | $0.32 | $0.32 | $0.32 |
| Q3 2026 | 1 | $0.29 | $0.29 | $0.29 |
| Q4 2026 | 1 | $0.29 | $0.29 | $0.29 |
| Q1 2027 | 1 | $0.72 | $0.72 | $0.72 |
| Q2 2027 | 1 | $0.75 | $0.75 | $0.75 |
| Q3 2027 | 1 | $0.74 | $0.74 | $0.74 |
| Q4 2027 | 1 | $0.75 | $0.75 | $0.75 |
| Q1 2028 | 1 | $1.62 | $1.62 | $1.62 |
| Q2 2028 | 1 | $1.68 | $1.68 | $1.68 |
| Q3 2028 | 1 | $1.66 | $1.66 | $1.66 |
| Q4 2028 | 1 | $1.70 | $1.70 | $1.70 |
Humacyte, Inc. Earnings Date And Information
Humacyte, Inc. last posted its earnings results on Friday, November 8th, 2024. The company reported $-0.33 earnings per share for the quarter, missing analysts' consensus estimates of $-0.26 by $0.07. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Humacyte, Inc. has generated $-1 earnings per share over the last year ($-1.07 diluted earnings per share) and currently has a price-to-earnings ratio of -3.62. Humacyte, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based on prior year's report dates.
Humacyte, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | -$0.26 | -$0.33 | -0.07 | $300,000 | $0 |
| 08/13/2024 | Q2 2024 | -$0.23 | -$0.48 | -0.25 | $20,000 | $0 |
| 05/13/2024 | Q1 2024 | -$0.29 | $0 | |||
| 03/28/2024 | Q4 2023 | -$0.24 | $10.79 M | |||
| 11/09/2023 | Q3 2023 | -$0.25 | -$0.25 | 0 | $66,667 | $0 |
| 08/14/2023 | Q2 2023 | -$0.22 | -$0.22 | 0 | $66,667 | $0 |
| 05/12/2023 | Q1 2023 | -$0.22 | -$0.60 | -0.38 | $0 | |
| 03/24/2023 | Q4 2022 | -$0.24 | $0.13 | 0.37 | $0 | |
| 11/10/2022 | Q3 2022 | -$0.21 | -$0.25 | -0.04 | $203,500 | $31,000 |
| 08/12/2022 | Q2 2022 | -$0.22 | $0.36 | 0.58 | $235,400 | $1.30 M |
| 05/13/2022 | Q1 2022 | -$0.21 | -$0.16 | 0.05 | $233,000 | |
| 03/29/2022 | Q4 2021 | -$0.19 | $0.41 | 0.6 | $177,000 | |
| 11/12/2021 | Q3 2021 | -$0.72 | $371,667 | $241,000 | ||
| 08/16/2021 | Q2 2021 | -$0.56 | -$0.17 | 0.39 | $350,000 | $690,000 |
| 05/17/2021 | Q1 2021 | -$0.90 | -$0.20 | 0.7 | $155,000 | |
| 02/16/2021 | Q4 2020 | -$5.61 | $124,000 | |||
| 11/12/2020 | Q3 2020 | -$1.43 | $914,000 | |||
| 06/29/2020 | Q2 2020 | -$0.68 | $198,000 | |||
| 03/30/2020 | Q1 2020 | -$0.81 | $255,000 |
Humacyte, Inc. Earnings: FAQ's
When is Humacyte, Inc.'s earnings date?
Humacyte, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates.
How can I listen to Humacyte, Inc.'s earnings conference
call?
The conference call for Humacyte, Inc.'s latest earnings report can be listened to online.
How can I read Humacyte, Inc.'s conference call transcript?
The conference call transcript for Humacyte, Inc.'s latest earnings report can be read online.
How much profit does Humacyte, Inc. generate each year?
Humacyte, Inc. (:HUMA) has a recorded net income of $0. Humacyte, Inc. has generated $-1.07 earnings per share over the last four quarters.
What is Humacyte, Inc.'s price-to-earnings ratio?
Humacyte, Inc. (:HUMA) has a price-to-earnings ratio of -3.62 and price/earnings-to-growth ratio is 0.57.